MicroRNA-192* impairs adipocyte triglyceride storage

Area of Science:

• Metabolic research
• Molecular biology
• Adipocyte biology

Background:

• MicroRNAs (miRNAs) play crucial roles in metabolic regulation.
• miR-192* (miR-192-3p), a less-studied miRNA, is derived from the same precursor as miR-192 (miR-192-5p), which is linked to metabolic diseases.
• Understanding miR-192*'s function in adipose tissue is essential for metabolic health.

Purpose of the Study:

• To investigate the expression of miR-192* in visceral adipose tissue (VAT) of obese individuals.
• To elucidate the functional role of miR-192* in human adipocyte differentiation and lipid metabolism.
• To identify the molecular targets of miR-192* involved in lipogenesis.

Main Methods:

• Expression analysis of miR-192* in VAT from obese and less obese subjects.
• Overexpression of miR-192* in cultured human adipocytes.
• Analysis of adipogenic differentiation markers and cellular triglyceride content.
• Transcriptomic profiling and validation of target genes using qPCR and Western blot.

Main Results:

• miR-192* expression in VAT negatively correlated with serum triglyceride and positively with HDL in morbidly obese subjects.
• miR-192* expression correlated negatively with body mass index in a less obese cohort.
• Overexpression of miR-192* in adipocytes reduced cellular triglyceride content and expression of adipocyte markers aP2 and perilipin 1.
• Transcriptomic analysis revealed miR-192* impacts lipogenic genes, including direct targeting of SCD and ALDH3A2, and reduced expression of SCARB1.

Conclusions:

• miR-192* is a novel regulator of adipocyte differentiation and lipid homeostasis.
• The findings suggest miR-192* plays a significant role in managing lipid metabolism within adipose tissue.
• miR-192* represents a potential therapeutic target for obesity and related metabolic disorders.